Lifevantage Corp financial data

Symbol
LFVN on Nasdaq
Industry
Pharmaceutical Preparations
Location
3300 Triumph Blvd, Suite 700, Lehi, Utah
Fiscal year end
June 30
Former names
LIFELINE THERAPEUTICS, INC. (to 12/6/2006), YAAK RIVER RESOURCES INC (to 9/28/2004)
Latest financial report
10-Q - Q1 2024 - May 2, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 181 % -5.44%
Quick Ratio 69 % -13.1%
Debt-to-equity 118 % +4.72%
Return On Equity 12.2 %
Return On Assets 5.61 %
Operating Margin 1.96 % +30.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 12.7 M shares -0.74%
Common Stock, Shares, Outstanding 12.7 M shares -0.65%
Entity Public Float 44.2 M USD -45.6%
Common Stock, Value, Issued 1 K USD 0%
Weighted Average Number of Shares Outstanding, Basic 12.4 M shares -1.51%
Weighted Average Number of Shares Outstanding, Diluted 13 M shares +1.69%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 205 M USD -2.22%
Research and Development Expense 600 K USD -14.3%
Operating Income (Loss) 4.02 M USD +27.6%
Nonoperating Income (Expense) 171 K USD -120%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 4.2 M USD +836%
Income Tax Expense (Benefit) 597 K USD -53.7%
Net Income (Loss) Attributable to Parent 3.6 M USD +62.3%
Earnings Per Share, Basic 0.28 USD/shares +62.5%
Earnings Per Share, Diluted 0.28 USD/shares +62.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 21.6 M USD +7.01%
Accounts Receivable, after Allowance for Credit Loss, Current 2.14 M USD -9.27%
Inventory, Net 15.2 M USD -17.8%
Assets, Current 37.8 M USD -14.8%
Deferred Income Tax Assets, Net 4.93 M USD +120%
Property, Plant and Equipment, Net 8.35 M USD -11.7%
Operating Lease, Right-of-Use Asset 9.38 M USD +1.44%
Intangible Assets, Net (Excluding Goodwill) 356 K USD -27%
Other Assets, Noncurrent 496 K USD -62.1%
Assets 61.3 M USD -8.61%
Accounts Payable, Current 6.95 M USD +19.4%
Accrued Liabilities, Current 7.93 M USD +0.06%
Contract with Customer, Liability, Current 700 K USD
Liabilities, Current 22.5 M USD +5.01%
Operating Lease, Liability, Noncurrent 11.9 M USD -0.56%
Other Liabilities, Noncurrent 211 K USD -33.9%
Liabilities 34.5 M USD +2.67%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.72 M USD -75.8%
Retained Earnings (Accumulated Deficit) -108 M USD -8.79%
Stockholders' Equity Attributable to Parent 26.8 M USD -20%
Liabilities and Equity 61.3 M USD -8.61%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 4.77 M USD
Net Cash Provided by (Used in) Financing Activities -6.67 M USD -1933%
Net Cash Provided by (Used in) Investing Activities -1.13 M USD -55.8%
Common Stock, Shares Authorized 40 M shares 0%
Common Stock, Shares, Issued 12.7 M shares -0.65%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.2 M USD -24.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 17.4 M USD -11%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 704 K USD +4.3%
Deferred Tax Assets, Gross 7.86 M USD +17.4%
Operating Lease, Liability 13.5 M USD -1.21%
Payments to Acquire Property, Plant, and Equipment 1.13 M USD +55.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 1.13 M USD +9.07%
Lessee, Operating Lease, Liability, to be Paid 15.2 M USD -3.3%
Operating Lease, Liability, Current 1.68 M USD -5.58%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.07 M USD +28.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.03 M USD +4.92%
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure 0%
Deferred Income Tax Expense (Benefit) -1.7 M USD +2.96%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.65 M USD -17.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.08 M USD +26.4%
Deferred Tax Assets, Operating Loss Carryforwards 250 K USD -14.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5 M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.06 M USD +21.9%
Operating Lease, Payments 2.33 M USD -19.8%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 918 K USD +9.16%
Interest Expense 7 K USD -50%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%